RETRACTION: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study (Retraction of Vol 5, Pg 785, 2017)

被引：0

作者：

Waterer, Grant ^{[1
]}

机构：

[1] Lancet Resp Med, London EC2Y 5AS, England

来源：

LANCET RESPIRATORY MEDICINE | 2024年 / 12卷 / 04期

关键词：

D O I：

10.1016/S2213-2600(24)00029-8

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：262 / 263

页数：2

共 50 条

[31] Efficacy and safety of incobotulinumtoxinA in the combined treatment of upper facial lines: Results of the first prospective randomised, double-blind, placebo-controlled, multicentre phase III study
Rzany, Berthold
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB16 - AB16
[32] Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial (vol 5, pg 597, 2017)
Petrie, J. R.
Chaturvedi, N.
Ford, I
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (11): : E7 - E7
[33] Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial (vol 5, pg 597, 2017)
Petrie, J. R.
Chaturvedi, N.
Ford, I
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08): : E5 - E5
[34] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (vol 397, pg 2070, 2021)
Rovin, B. H.
Teng, Y. K. O.
Ginzler, E. M.
LANCET, 2021, 397 (10289): : 2048 - 2048
[35] Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
Mirsaeidi, Mehdi
Baughman, Robert P.
Sahoo, Debasis
Tarau, Eva
PULMONARY THERAPY, 2023, 9 (02) : 237 - 253
[36] Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
Mehdi Mirsaeidi
Robert P. Baughman
Debasis Sahoo
Eva Tarau
Pulmonary Therapy, 2023, 9 : 237 - 253
[37] Safety and efficacy of tramadol in the treatment of idiopathic detrusor overactivity: A double-blind, placebo-controlled, randomized study (Retraction of vol 61, pg 456j, 2006)
Safarinejad, M. R.
Hosseini, S. Y.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (01) : 216 - 216
[38] Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Diamond, Michael P.
Carr, Bruce
Dmowski, W. Paul
Koltun, William
O'Brien, Chris
Jiang, Ping
Burke, Joshua
Jimenez, Roland
Garner, Elizabeth
Chwalisz, Kristof
REPRODUCTIVE SCIENCES, 2014, 21 (03) : 363 - 371
[39] Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Michael P. Diamond
Bruce Carr
W. Paul Dmowski
William Koltun
Chris O’Brien
Ping Jiang
Joshua Burke
Roland Jimenez
Elizabeth Garner
Kristof Chwalisz
Reproductive Sciences, 2014, 21 : 363 - 371
[40] Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials (vol 3, pg 355, 2015)
Castro, M.
Zangrilli, J.
Wechsler, M. E.
LANCET RESPIRATORY MEDICINE, 2016, 4 (10): : E50 - E50

← 1 2 3 4 5 →